[(1R)-1-naphthalen-2-ylethyl] (3R)-1-methyl-2-oxo-3-phenylpyrrolidine-3-carboxylate
C24H23NO3 — CID 139115469
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(1R)-1-naphthalen-2-ylethyl] (3R)-1-methyl-2-oxo-3-phenylpyrrolidine-3-carboxylate
[(1R)-1-naphthalen-2-ylethyl] (3R)-1-methyl-2-oxo-3-phenylpyrrolidine-3-carboxylate (PubChem CID 139115469) has the molecular formula C24H23NO3 and a molecular weight of 373.45 g/mol. Its IUPAC name is [(1R)-1-naphthalen-2-ylethyl] (3R)-1-methyl-2-oxo-3-phenylpyrrolidine-3-carboxylate.
Molecular Properties
| Compound Name | [(1R)-1-naphthalen-2-ylethyl] (3R)-1-methyl-2-oxo-3-phenylpyrrolidine-3-carboxylate |
|---|---|
| PubChem CID | 139115469 |
| Molecular Formula | C24H23NO3 |
| Molecular Weight | 373.45 g/mol |
| Exact Mass | 373.17 |
| IUPAC Name | [(1R)-1-naphthalen-2-ylethyl] (3R)-1-methyl-2-oxo-3-phenylpyrrolidine-3-carboxylate |
| SMILES | C[C@@H](OC(=O)[C@@]1(c2ccccc2)CCN(C)C1=O)c1ccc2ccccc2c1 |
| InChI | InChI=1S/C24H23NO3/c1-17(19-13-12-18-8-6-7-9-20(18)16-19)28-23(27)24(14-15-25(2)22(24)26)21-10-4-3-5-11-21/h3-13,16-17H,14-15H2,1-2H3/t17-,24-/m1/s1 |
| InChIKey | JQVXTRHKANHEQB-MZNJEOGPSA-N |
| XLogP | 4.24 |
| TPSA | 46.61 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 373.45 |
| LogP ≤ 5 | 4.24 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139115469 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.